ATLANTA, July 12, 2024--Alzamend Neuro Announces Reverse Stock Split
ATLANTA, May 22, 2024--Alzamend Neuro Announces Favorable Decision from Nasdaq Hearings Panel
ATLANTA, May 14, 2024--Alzamend Neuro Announces Initial Closing of Private Placement; Investor Purchase Up to $25 Million of Preferred Shares; Proceeds for Clinical Trials